Improvement of the Coxsackievirus B3 (CVB3)-induced mice-myocarditis model by development of a pancreas-attenuated virus

被引：0
|
作者：
Pryshliak, M. [1 ]
Pinkert, S. [1 ]
Hazini, A. [1 ]
Fechner, H. [1 ]
机构：
[1] Tech Univ Berlin, Berlin, Germany
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P423
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [1] Improvement of coxsackievirus B3 (CVB3) myocarditis model by use of miR-375-regulated CVB3
    Pryshliak, M.
    Knoch, K. P.
    Klingel, K.
    Hazini, A.
    Pinkert, S.
    Fechner, H.
    HUMAN GENE THERAPY, 2017, 28 (12) : A45 - A45
  • [2] A PAR 2 knockout reduces the Coxsackievirus B3 (CVB3) replication in the cardiac muscle and protects mice from severe CVB3 induced myocarditis
    Weithaeuser, A.
    Boltzen, U.
    Savvatis, K.
    Klingel, K.
    Schultheiss, H. P.
    Rauch, U.
    EUROPEAN HEART JOURNAL, 2010, 31 : 307 - 307
  • [3] Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis
    Zhang, Alian
    Zhang, Huili
    Wu, Shiyao
    INFLAMMATION RESEARCH, 2010, 59 (04) : 255 - 262
  • [4] Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis
    Alian Zhang
    Huili Zhang
    Shiyao Wu
    Inflammation Research, 2010, 59 : 255 - 262
  • [5] Neutralizing Activity Induced by the Attenuated Coxsackievirus B3 Sabin3-like Strain Against CVB3 Infection
    Jrad-Battikh, Nadia
    Souii, Amira
    Oueslati, Leila
    Aouni, Mahjoub
    Hober, Didier
    Gharbi, Jawhar
    Ben M'hadheb-Gharbi, Manel
    CURRENT MICROBIOLOGY, 2014, 68 (04) : 503 - 509
  • [6] Neutralizing Activity Induced by the Attenuated Coxsackievirus B3 Sabin3-like Strain Against CVB3 Infection
    Nadia Jrad-Battikh
    Amira Souii
    Leila oueslati
    Mahjoub Aouni
    Didier hober
    Jawhar Gharbi
    Manel Ben M’hadheb-Gharbi
    Current Microbiology, 2014, 68 : 503 - 509
  • [7] SOLUBLE SERUM FACTOR(S) TRANSFER PROTECTION AGAINST COXSACKIEVIRUS-B3 (CVB3)-INDUCED MYOCARDITIS IN MICE
    GODENY, EK
    GAUNTT, CJ
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 574 - 574
  • [8] Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3(m)) and comparison to other infectious CVB3 cDNAs
    Lee, C
    Maull, E
    Chapman, N
    Tracy, S
    Wood, J
    Gauntt, C
    VIRUS RESEARCH, 1997, 50 (02) : 225 - 235
  • [9] An intranasal attenuated Coxsackievirus B3 vaccine induces strong systemic and mucosal immunity against CVB3 lethal challenge
    Deng, Huixiong
    Li, Yanlei
    He, Xuanting
    Wang, Haoyang
    Wang, Shenmiao
    Zhang, Hengyao
    Zhu, Jiacheng
    Gu, Liming
    Li, Rui
    Wang, Gefei
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (08)
  • [10] Autoimmunity in coxsackievirus B3 induced myocarditis
    Huber, SA
    AUTOIMMUNITY, 2006, 39 (01) : 55 - 61
12345